A phase III study in metastatic colorectal cancer has been slammed by a haematologist-oncologist as the “single worst reported randomised trial” he has ever read. Presented at at the European Society for Medical Oncology conference in Barcelona and published simultaneously in the NEJM, the BEACON trial purported to show that triple therapy targeting BRAF mutations ...
Colorectal cancer trial slammed as ‘the single worst reported RCT’
By Nicola Garrett
24 Oct 2019